001     182336
005     20240229145716.0
024 7 _ |a 10.1002/eji.202249816
|2 doi
024 7 _ |a pmid:36303448
|2 pmid
024 7 _ |a 0014-2980
|2 ISSN
024 7 _ |a 1521-4141
|2 ISSN
024 7 _ |a altmetric:137856977
|2 altmetric
037 _ _ |a DKFZ-2022-02579
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Lutz, Manfred B
|b 0
245 _ _ |a Guidelines for mouse and human DC generation.
260 _ _ |a Weinheim
|c 2023
|b Wiley-VCH
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1699001766_23211
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2023 Nov;53(11):e2249816
520 _ _ |a This article is part of the Dendritic Cell Guidelines article series, which provides a collection of state-of-the-art protocols for the preparation, phenotype analysis by flow cytometry, generation, fluorescence microscopy, and functional characterization of mouse and human dendritic cells (DC) from lymphoid organs and various non-lymphoid tissues. This article provides protocols with top ticks and pitfalls for preparation and successful generation of mouse and human DC from different cellular sources, such as murine BM and HoxB8 cells, as well as human CD34+ cells from cord blood, BM, and peripheral blood or peripheral blood monocytes. We describe murine cDC1, cDC2, and pDC generation with Flt3L and the generation of BM-derived DC with GM-CSF. Protocols for human DC generation focus on CD34+ cell culture on OP9 cell layers for cDC1, cDC2, cDC3, and pDC subset generation and DC generation from peripheral blood monocytes (MoDC). Additional protocols include enrichment of murine DC subsets, CRISPR/Cas9 editing, and clinical grade human DC generation. While all protocols were written by experienced scientists who routinely use them in their work, this article was also peer-reviewed by leading experts and approved by all co-authors, making it an essential resource for basic and clinical DC immunologists.
536 _ _ |a 316 - Infektionen, Entzündung und Krebs (POF4-316)
|0 G:(DE-HGF)POF4-316
|c POF4-316
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Dendritic cells
|2 Other
650 _ 7 |a Generation
|2 Other
650 _ 7 |a In vitro
|2 Other
650 _ 7 |a Isolation
|2 Other
700 1 _ |a Ali, Shafaqat
|b 1
700 1 _ |a Audiger, Cindy
|b 2
700 1 _ |a Autenrieth, Stella
|0 P:(DE-He78)d3dbba28fe1239effd15962787cbc363
|b 3
|u dkfz
700 1 _ |a Berod, Luciana
|b 4
700 1 _ |a Bigley, Venetia
|b 5
700 1 _ |a Cyran, Laura
|b 6
700 1 _ |a Dalod, Marc
|b 7
700 1 _ |a Dörrie, Jan
|b 8
700 1 _ |a Dudziak, Diana
|b 9
700 1 _ |a Flórez-Grau, Georgina
|b 10
700 1 _ |a Giusiano, Lucila
|b 11
700 1 _ |a Godoy, Gloria J
|b 12
700 1 _ |a Heuer, Marion
|b 13
700 1 _ |a Krug, Anne B
|b 14
700 1 _ |a Lehmann, Christian H K
|b 15
700 1 _ |a Mayer, Christian T
|b 16
700 1 _ |a Naik, Shalin H
|b 17
700 1 _ |a Scheu, Stefanie
|b 18
700 1 _ |a Schreibelt, Gerty
|b 19
700 1 _ |a Segura, Elodie
|b 20
700 1 _ |a Seré, Kristin
|b 21
700 1 _ |a Sparwasser, Tim
|b 22
700 1 _ |a Tel, Jurjen
|b 23
700 1 _ |a Xu, Huaming
|b 24
700 1 _ |a Zenke, Martin
|b 25
773 _ _ |a 10.1002/eji.202249816
|g p. eji.202249816
|0 PERI:(DE-600)1491907-2
|n 11
|p e2249816
|t European journal of immunology
|v 53
|y 2023
|x 0014-2980
909 C O |p VDB
|o oai:inrepo02.dkfz.de:182336
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)d3dbba28fe1239effd15962787cbc363
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-316
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Infektionen, Entzündung und Krebs
|x 0
914 1 _ |y 2022
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2021-02-02
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-02
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-08-19
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-19
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR J IMMUNOL : 2022
|d 2023-08-19
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b EUR J IMMUNOL : 2022
|d 2023-08-19
920 1 _ |0 I:(DE-He78)F171-20160331
|k F171
|l Dentritische Zellen bei Infektionen und Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)F171-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21